Overexpressed ABCB1 Induces Olaparib-Taxane Cross-Resistance in Advanced Prostate Cancer()

Castration-resistant prostate cancer remains as an incurable disease. Exploiting DNA damage repair defects via inhibition of poly (ADP-ribose) polymerase (PARP) is becoming an attractive therapeutic option. The TOPARP-A clinical trial demonstrated that the PARP inhibitor olaparib may be an effective...

Descripción completa

Detalles Bibliográficos
Autores principales: Lombard, Alan P, Liu, Chengfei, Armstrong, Cameron M, D'Abronzo, Leandro S, Lou, Wei, Chen, Hongwu, Dall'Era, Marc, Ghosh, Paramita M, Evans, Christopher P, Gao, Allen C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2019
Materias:
Original article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6510951/
https://www.ncbi.nlm.nih.gov/pubmed/31075528
http://dx.doi.org/10.1016/j.tranon.2019.04.007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6510951/
https://www.ncbi.nlm.nih.gov/pubmed/31075528
http://dx.doi.org/10.1016/j.tranon.2019.04.007

Ejemplares similares